Targeting HER2 for localised oesophageal cancer

Lancet Oncol. 2022 Feb;23(2):188-190. doi: 10.1016/S1470-2045(22)00004-3. Epub 2022 Jan 14.

Authors

Florian Lordick¹, Radka Obermannová², Elizabeth C Smyth³

Affiliations

¹ Department of Medicine II and University Cancer Center Leipzig, University of Leipzig Medical Center, Leipzig 04103, Germany. Electronic address: florian.lordick@medizin.uni-leipzig.de.
² Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
³ Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

PMID: 35038428
DOI: 10.1016/S1470-2045(22)00004-3

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Esophageal Neoplasms* / drug therapy
Esophageal Neoplasms* / genetics
Esophagogastric Junction
Humans